Skip to content

Role of iTBS-modulated frontal-vagal network in ameliorating knee osteoarthritis pain

Role of iTBS-modulated frontal-vagal network in ameliorating knee osteoarthritis pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105479
Enrollment
Unknown
Registered
2025-07-04
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis of the knee

Interventions

Intervention group:iTBS stimulation + conventional physiotherapy
Phase 1: Test group:All stimulation that the participant will receive, including left dorsolateral prefrontal iTBS true stimulation, right dorsolateral prefrontal iTBS true stimulation, pseudostimulat

Sponsors

Guangzhou sport university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Healthy subjects: 1. Between 18 and 65 years of age Patients with osteoarthritis of the knee: 1. Aged between 18 and 75 years old and able to give consent. 2. Meet the diagnostic criteria for osteoarthritis of the knee according to the Chinese Osteoarthritis Guidelines and report having unilateral or bilateral knee OA pain; 3. Chronic knee pain (lasting at least 3 months) with a visual analogue scale (VAS) score of =5/10.

Exclusion criteria

Exclusion criteria: Healthy subjects: 1. Contraindications to TMS (including, but not limited to, metal inside the head, excluding dental work, professional drivers, pregnant or breastfeeding, history of seizures);. 2. History of neurologic or psychiatric disorders or use of psychotropic medications; and 3. History of cardiac abnormalities or current cardiac abnormalities or taking medications related to cardiac disease. Patients with osteoarthritis of the knee: 1. Contraindication to TMS. 2. Significant medical or neurological illness unrelated to the pain condition 3. Planned total knee replacement surgery or other major treatment change within 1 month of initial evaluation. 4. Intra-articular injection therapy within the past 4 weeks. 5. Taking centrally active medications other than stable antidepressants or opioid analgesics. 6. Taking medication, alcohol or recreational drugs that are thought to increase the risk of seizures and/or syncope

Design outcomes

Primary

MeasureTime frame
heart rate variability index;Visual Analogue Scale;Western Ontario and McMaster Universities Arthritis Index;seed-based function connectivity;

Secondary

MeasureTime frame
Short Form 36 Health Survey;Pain Catastrophizing Scale;oxyhemoglobin concentration;

Countries

China

Contacts

Public ContactHou Xiaohui

Guangzhou sport university

lilyhxh@163.com+86 138 2218 7866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026